146 related articles for article (PubMed ID: 17369780)
41. [Tumor markers in uterine cancers].
Fukasawa I; Kousaka N; Kun Z; Inaba N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
[TBL] [Abstract][Full Text] [Related]
42. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
[TBL] [Abstract][Full Text] [Related]
43. Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer.
Gitsch G; Kainz C; Joura E; Fröhlich B; Bieglmayr C; Tatra G
Anticancer Res; 1992; 12(4):1247-9. PubMed ID: 1503417
[TBL] [Abstract][Full Text] [Related]
44. New concepts in the diagnosis and prognosis of endometrial carcinoma.
Sasano H; Watanabe K; Ito K; Sato S; Yajima A
Pathol Annu; 1994; 29 ( Pt 2)():31-49. PubMed ID: 7936750
[TBL] [Abstract][Full Text] [Related]
45. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
Ławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
[TBL] [Abstract][Full Text] [Related]
46. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
[TBL] [Abstract][Full Text] [Related]
47. [Proteomics and biomarkers for detection of endometrial carcinoma].
Kacerovský M; Tosner J
Ceska Gynekol; 2009 Aug; 74(4):274-8. PubMed ID: 20564981
[TBL] [Abstract][Full Text] [Related]
48. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
[TBL] [Abstract][Full Text] [Related]
49. [Methodologic and organizational principles of selective screening for cervical, endometrial and ovarian carcinoma].
Zalutskiĭ IV; Vishnevskaia EE; Kurian LM
Vopr Onkol; 2006; 52(1):74-7. PubMed ID: 16715709
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of statistical discrimination employing serum TA-4, TPA, and CEA levels in uterine cervical cancer.
Yabushita H; Ogawa A; Masuda T; Noguchi M; Nakanishi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1770-6. PubMed ID: 3782958
[TBL] [Abstract][Full Text] [Related]
51. [Molecular prognostic factors and pathogenesis of endometrial cancer].
Mícková I; Pilka R; L'ubuský M; Kudela M
Ceska Gynekol; 2006 Jul; 71(4):355-60. PubMed ID: 16956055
[TBL] [Abstract][Full Text] [Related]
52. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
Geyer H; Schwörer D; Pfleiderer A
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
[TBL] [Abstract][Full Text] [Related]
53. Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.
Viswanathan AN; Buttin BM; Kennedy AM
Radiographics; 2008; 28(1):289-307. PubMed ID: 18444279
[No Abstract] [Full Text] [Related]
54. [Gynecologic malignancies].
Kato H
Nihon Rinsho; 1996 Jun; 54(6):1637-41. PubMed ID: 8691622
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.
Volgger B; Aspisirengil C; Genser-Krimbacher E; Ciresa-Koenig A; Daxenbichler G; Fuchs D; Windbichler G; Marth C
Cancer Lett; 2008 Apr; 262(2):183-9. PubMed ID: 18226853
[TBL] [Abstract][Full Text] [Related]
56. [Early diagnosis of relapses of cervical and endometrial carcinomas (author's transl)].
Leitsmann H; Prager W; Baier D; Bolck M; Schneider A; Kühndel K; Dietzsch J
Arch Geschwulstforsch; 1980; 50(4):349-58. PubMed ID: 7006559
[TBL] [Abstract][Full Text] [Related]
57. Cervical, Ovarian and Endometrial Tumor Markers: Potential Clinical Value.
Malhone C; Longatto-Filho A
Semin Ultrasound CT MR; 2019 Aug; 40(4):350-357. PubMed ID: 31375174
[TBL] [Abstract][Full Text] [Related]
58. Detection of Circulating Tumor Cell-Related Markers in Gynecologic Cancer Using Microfluidic Devices: A Pilot Study.
Law KS; Huang CE; Chen SW
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768623
[TBL] [Abstract][Full Text] [Related]
59. Proteomics of endometrial cancer diagnosis, treatment, and prognosis.
Mittal P; Klingler-Hoffmann M; Arentz G; Zhang C; Kaur G; Oehler MK; Hoffmann P
Proteomics Clin Appl; 2016 Mar; 10(3):217-29. PubMed ID: 26541900
[TBL] [Abstract][Full Text] [Related]
60. [Proteomics and biomarkers for detection of cervical cancer].
Kacerovský M; Tosner J
Ceska Gynekol; 2009 Oct; 74(5):335-8. PubMed ID: 20063836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
